Back to Search
PREDIMAN SHAH, MD
MD
Cardiovascular Disease Physician
NPI: 1447394036IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
A31604(CA)
Cardiovascular Disease PhysicianPrimary
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
A31604(CA)
CMS Specialties
PrimaryCARDIOVASCULAR DISEASE (CARDIOLOGY)
Education
OTHER
Class of 1969
Research & Publications (20)
Apolipoprotein A-I/HDL infusion therapy for plaque stabilization-regression: a novel therapeutic approach.
PMID 17430166·Curr Pharm Des·2007
6-review
Emerging HDL-based therapies for atherothrombotic vascular disease.
PMID 17378977·Curr Treat Options Cardiovasc Med·2007
8-other
Inhibition of CETP as a novel therapeutic strategy for reducing the risk of atherosclerotic disease.
PMID 17121756·Eur Heart J·2007
6-review
High-density lipoprotein mimetics: focus on synthetic high-density lipoprotein.
PMID 18047855·Am J Cardiol·2007
8-other
Immunomodulation of atherosclerosis with a vaccine.
PMID 16306920·Nat Clin Pract Cardiovasc Med·2005
6-review
Apolipoprotein A-I mimetic peptides: potential role in atherosclerosis management.
PMID 16297766·Trends Cardiovasc Med·2005
6-review
Ranolazine: a new drug and a new paradigm for management of myocardial ischemia and angina.
PMID 15346105·Rev Cardiovasc Med·2004
8-other
Vaccination for atherosclerosis: a novel therapeutic paradigm.
PMID 15606356·Expert Rev Vaccines·2004
6-review
Immunotherapy for atherosclerosis: an emerging paradigm.
PMID 15580158·Rev Cardiovasc Med·2004
6-review
Pathophysiology of plaque rupture and the concept of plaque stabilization.
PMID 14621447·Cardiol Clin·2003
6-review
Emerging non-statin LDL-lowering therapies for dyslipidemia and atherosclerosis.
PMID 12949442·Rev Cardiovasc Med·2003
6-review
The calcium channel blocker lacidipine slows the progression of carotid atherosclerosis.
PMID 12949447·Rev Cardiovasc Med·2003
8-other
Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins: an idea whose time for testing is coming, part I.
PMID 11696481·Circulation·2001
6-review
Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins: an idea whose time for testing is coming, part II.
PMID 11705831·Circulation·2001
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 8700 BEVERLY BLVD
LOS ANGELES, CA 90048 - Phone
- (310) 423-3844
Quick Facts
- NPI
- 1447394036
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 57
- Publications
- 20
Are you this provider?
Claim Your Profile